EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Simultaneous Liver-Kidney Transplantation versus Liver Transplantation in End-Stage Liver Disease Patients with Kidney Dysfunction

Sarah Bouari, Yitian Fang, Jacqueline van de Wetering, Vincent E de Meijer, Robert A Pol, Stefan P Berger, Wojciech G Polak, Hans Blokzijl, Aiko P J de Vries, Minneke J Coenraad, Hwai-Ding Lam, Dorottya K de Vries und 4 weitere

European Surgical Research · 2025

DOI: 10.1159/000550008 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Surgical Research, 2025. Verfasst von Sarah Bouari und 15 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC Transplant Institute, Department of Surgery, Division of HPB and Transplant Surgery, University Medical Center Rotterdam, Rotterdam, The N…. Hauptthemen laut MEDLINE: Liver Transplantation, End Stage Liver Disease, Kidney Transplantation, Renal Insufficiency, Chronic. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The role of simultaneous liver-kidney transplantation (SLKT) in end-stage liver disease patients with varying kidney dysfunction remains unclear. This study aims to compare clinical outcomes of SLKT recipients with those undergoing liver transplant alone (LTA) with comparable kidney dysfunction.

Methods

This retrospective cohort study included the SLKT cohort (n = 52) from the Dutch Organ Transplantation Registration and the LTA cohort (n = 829) from Erasmus Medical Center between 2000 and 2020. Patients were stratified by pretransplant renal function (chronic kidney disease [CKD] stages 3b–5) and pretransplant renal replacement therapy (RRT) status. Patient and graft survival, and renal function were compared across renal function strata.

Results

Across CKD stages 3b and 4, there was no statistically significant difference in overall survival rates (p = 0.59 and p = 0.23, respectively). For patients with CKD stage 5 or RRT, patient survival rates at 1, 3, and 5 years posttransplant were significantly lower in the LTA group (60.3%, 51.7%, and 51.7%, respectively) compared to the SLKT group (90.0%, 90.0%, and 80.8%, p = 0.048). Death-censored liver graft survival rates at 1, 3, and 5 years were also significantly lower in the LTA group (59.8%, 49.9%, and 49.9%) versus SLKT group (86.4%, 86.4%, and 77.0%, p = 0.048). Cox proportional hazards model confirmed the association between SLKT and improved patient survival (HR 0.31, 95% CI: 0.10–0.98, p = 0.046).

Conclusion

For patients with CKD stage 5 or those on pretransplant RRT, SLKT was associated with better survival outcomes compared to LTA. Primary etiology of liver disease and severity of kidney dysfunction should be considered when determining SLKT eligibility. Due to the limited group size, these findings should be interpreted with caution and further validated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationEnd Stage Liver DiseaseKidney TransplantationRenal Insufficiency, ChronicHumansMaleFemaleRetrospective StudiesMiddle AgedAdultGraft Survival

Stichwörter der Autor:innen

Acute liver failureEnd-stage liver diseaseGraft survivalKidney transplantationLiver transplantation

Autor:innen und Institutionen

  • Erasmus MC Transplant Institute, Department of Surgery, Division of HPB and Transplant Surgery, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Erasmus MC Transplant Institute, Department of Internal Medicine, Section of Nephrology and Transplantation, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • UMCG Comprehensive Transplant Center, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • UMCG Comprehensive Transplant Center, Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • UMCG Comprehensive Transplant Center, Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Leiden Transplant Center, Department of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.

Zitieren

APA

Bouari, S., Fang, Y., van de Wetering, J., de Meijer, V. E., Pol, R. A., Berger, S. P., Polak, W. G., Blokzijl, H., de Vries, A. P. J., Coenraad, M. J., Lam, H. D., de Vries, D. K., Porte, R. J., den Hoed, C. M., IJzermans, J. N. M., & Minnee, R. C. (2025). Simultaneous Liver-Kidney Transplantation versus Liver Transplantation in End-Stage Liver Disease Patients with Kidney Dysfunction. European Surgical Research. https://doi.org/10.1159/000550008

Vancouver

Bouari S, Fang Y, van de Wetering J, de Meijer VE, Pol RA, Berger SP, et al. Simultaneous Liver-Kidney Transplantation versus Liver Transplantation in End-Stage Liver Disease Patients with Kidney Dysfunction. European Surgical Research. 2025. doi:10.1159/000550008

BibTeX
@article{Bouari2025,
  author = {Bouari, Sarah and Fang, Yitian and van de Wetering, Jacqueline and de Meijer, Vincent E and Pol, Robert A and Berger, Stefan P and Polak, Wojciech G and Blokzijl, Hans and de Vries, Aiko P J and Coenraad, Minneke J and Lam, Hwai-Ding and de Vries, Dorottya K and Porte, Robert J and den Hoed, Caroline M and IJzermans, Jan N M and Minnee, Robert C},
  title = {Simultaneous Liver-Kidney Transplantation versus Liver Transplantation in End-Stage Liver Disease Patients with Kidney Dysfunction},
  journal = {European Surgical Research},
  year = {2025},
  doi = {10.1159/000550008}
}
Kostenlos starten →